@FiercePharma: BMJ says no more clinical trial publications if actual data isn't open for outside review. More | Follow @FiercePharma
> Allergan ($AGN) is mulling the sale of its obesity business after Lap-Band sales dropped 21% for the third quarter; the company's profits managed to beat expectations on a 6% rise in overall sales. Report
> AstraZeneca ($AZN) says it will relax restrictions on employee travel and partipation in industry conferences. Report
> European regulators granted conditional approval to Takeda Pharmaceutical's non-Hodgkin lymphoma drug Adcetris, recently launched in the U.S. Report
> Stringent austerity measures will deliver a 15% savings in Spain's drug spending, which, together with unpaid pharma bills, has pushed the industry to "the brink of collapse," Farmaindustria says. Report
> Roche's ($RHHBY) Avastin won a new ovarian cancer indication from European regulators. Report
> The European Medicines Agency expanded use of Eli Lilly's ($LLY) erectile dysfunction drug Cialis to patients with enlarged-prostate symptoms. Report
> Poland's pharma market will lose steam this year, as new pricing policies send growth into negative territory. Report
> U.S. Centers for Disease Control and Prevention added three to the death toll in the ongoing meningitis outbreak linked to compounded drugs; it's now 28. Report
@FierceMedDev: Boston Sci snagged EU approval for its new stent with bioabsorbable coating. News | Follow @FierceMedDev
@MarkHFierce: Fidelity is investing $75M into Trivitron Healthcare, an Indian company focused on imaging and lab Dx. Release | Follow @MarkHFierce
@DamianFierce: The latest Cleveland Clinic top 10 innovations list includes some novel medical devices. Article | Follow @DamianFierce
> GI Dynamics moves toward FDA approval for weight-loss tech. Story
> OptiScan, maker of glucose monitoring devices, raises $2.6M. Item
Biotech News
@FierceBiotech: Ipsen braces for $153M write-off as troubled biotech partner declares bankruptcy. News | Follow @FierceBiotech
@JohnCFierce: Biocon (India) scouts R&D pact after GE unit grabs stake in research division. Story | Follow @JohnCFierce
@RyanMFierce: Biotech's boneyard: 2012 report on the dead, dying, disabled (and some reborn) biotech operations. Happy Halloween! Special Report | Follow @RyanMFierce
> Researchers nab $11M to fund second look at AstraZeneca's stockpile of failed drugs. Article
> Biogen streak lives on with upbeat PhIII results for hemophilia A therapy. Story
Drug Delivery News
> Twice-yearly opioid dependence implant steps closer to the market. Item
> Ocular Therapeutix eyes up positive results for OTX-TP2. Article
> Starpharma technology delivers 40-fold more docetaxel to tumor. Report
> Paclitaxel particles extend life threefold in mouse bladder cancer. News
Biomarkers News
> Seeing is believing: Biomarkers visible to the naked eye. Item
> Blood biomarker tags NeuVax's role in breast cancer treatment. Article
> Marking glimpses of activity for Lilly's Alzheimer drug after PhIII struggles. Report
> U.K. researchers spot new marker for prostate cancer prognosis. News
> Chromosome cap length predicts pancreatic cancer risk. Story
And Finally... Diabetes rates are soaring in Saudi Arabia as the government is pledging billions to improve healthcare. Report